Fusemachines Reports Revenue Growth And Operating Loss Improvements In Q3 2026 Results
| Fusemachines Inc. and Subsidiaries Condensed Consolidated Interim Balance Sheets (all amounts in USD, in thousands, except number of shares and per share data) | ||||||||
| September 30, 2026 | December 31, 2025 | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | 1,454 | 4,221 | ||||||
| Accounts receivable, net | 1,400 | 1,264 | ||||||
| Unbilled revenue | 16 | 16 | ||||||
| Prepaid expenses and other current assets | 575 | 753 | ||||||
| Customer incentive asset, current | 193 | - | ||||||
| Total current assets | 3,638 | 6,254 | ||||||
| Property and equipment, net | 244 | 305 | ||||||
| Customer incentive asset, non-current | 364 | - | ||||||
| Intangible assets, net | 259 | 206 | ||||||
| Deferred tax assets | 11 | 11 | ||||||
| Operating lease right-of-use assets | 482 | 744 | ||||||
| Other assets | 11 | 16 | ||||||
| Total assets | 5,009 | 7,536 | ||||||
| Liabilities and stockholders' deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | 4,527 | 5,012 | ||||||
| Accrued expenses and other current liabilities | 4,734 | 4,618 | ||||||
| Convertible notes payable, current | 1,245 | - | ||||||
| Related party loan payable, current | 300 | 300 | ||||||
| Forward purchase derivative liability | 708 | 9,692 | ||||||
| Operating lease liability, current | 45 | 85 | ||||||
| Short term debt | 64 | 342 | ||||||
| Cumulative mandatorily redeemable common and preferred stock liability, current | 1,063 | |||||||
| Total current liabilities | 12,686 | 20,049 | ||||||
| Accounts payable non-current | - | 143 | ||||||
| Warrant liability | 30 | 121 | ||||||
| Cumulative mandatorily redeemable common and preferred stock liability, non-current | - | 1,048 | ||||||
| Operating lease liability | 508 | 751 | ||||||
| Total liabilities | 13,224 | 22,112 | ||||||
| Commitments and Contingencies | ||||||||
| Stockholder's deficit: | ||||||||
| Convertible preferred stock ($0.0001 par value, 5,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; Nil shares issued as of September 30, 2026 and December 31, 2025, respectively; Nil shares outstanding as of September 30, 2026 and December 31, 2025) | - | - | ||||||
| Common stock ($0.0001 par value, 500,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 32,424,711 shares and 28,938,266 shares issued and outstanding as of September 30,2026 and December 31, 2025, respectively) | 4 | 3 | ||||||
| Additional paid in capital | 35,821 | 31,311 | ||||||
| Share subscription receivable | (738 | ) | (11,005 | ) | ||||
| Accumulated deficit | (43,573 | ) | (35,145 | ) | ||||
| Accumulated other comprehensive income | 271 | 260 | ||||||
| Total stockholders' deficit | (8,215 | ) | (14,576 | ) | ||||
| Total liabilities and stockholders' deficit | 5,009 | 7,536 |
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
| Fusemachines Inc. and Subsidiaries Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (all amounts in USD, in thousands, except number of shares and per share data) | ||||||||||||||||
| Three Months ended, September 30 | Nine Months ended, September 30 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||
| Revenue | 1,845 | 1,792 | 5,518 | 5,779 | ||||||||||||
| Cost of revenue | (864 | ) | (796 | ) | (2,626 | ) | (2,488 | ) | ||||||||
| Gross Profit | 981 | 996 | 2,892 | 3,291 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling and marketing | 356 | 293 | 1,151 | 934 | ||||||||||||
| General and administrative | 2,653 | 1,632 | 8,904 | 5,131 | ||||||||||||
| Research and development | 286 | 165 | 876 | 489 | ||||||||||||
| Total operating expenses | 3,295 | 2,090 | 10,931 | 6,554 | ||||||||||||
| Loss from operations | (2,314 | ) | (1,094 | ) | (8,039 | ) | (3,263 | ) | ||||||||
| Other (expense) income: | ||||||||||||||||
| Interest expense | (353 | ) | (74 | ) | (459 | ) | (213 | ) | ||||||||
| Loss on extinguishment of convertible notes payable | - | - | - | (391 | ) | |||||||||||
| Gain on extinguishment of payable | 105 | - | 612 | - | ||||||||||||
| Gain/(loss) on change in fair value of convertible notes and warrant liability | 42 | (61 | ) | 91 | (1,405 | ) | ||||||||||
| Loss on change in fair value of forward purchase derivative liability | (2,212 | ) | - | (604 | ) | - | ||||||||||
| Other (expense) income | 109 | 55 | 59 | 59 | ||||||||||||
| Total other (expense)/income, net | (2,309 | ) | (80 | ) | (301 | ) | (1,950 | ) | ||||||||
| Loss before income taxes | (4,623 | ) | (1,174 | ) | (8,340 | ) | (5,213 | ) | ||||||||
| Provision for income tax | - | - | (4 | ) | - | |||||||||||
| Net loss | (4,623 | ) | (1,174 | ) | (8,344 | ) | (5,213 | ) | ||||||||
| Deemed dividend related to Shortfall Warrants modification | (84 | ) | - | |||||||||||||
| Net loss attributable to common stockholders (i) | (4,623 | ) | (1,174 | ) | (8,428 | ) | (5,213 | ) | ||||||||
| Weighted-average common shares outstanding - basic and diluted (ii) | 30,586,609 | 7,672,654 | 29,502,942 | 7,406,332 | ||||||||||||
| Net loss per common share - basic and diluted (i/ii) | (0.15 | ) | (0.15 | ) | (0.29 | ) | (0.70 | ) | ||||||||
| Other Comprehensive income (loss) | ||||||||||||||||
| Net loss | (4,623 | ) | (1,174 | ) | (8,344 | ) | (5,213 | ) | ||||||||
| Change in foreign currency translation adjustment | 2 | 8 | 11 | 8 | ||||||||||||
| Total comprehensive loss | (4,621 | ) | (1,166 | ) | (8,333 | ) | (5,205 | ) |
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
| Fusemachines Inc. and Subsidiaries Condensed Consolidated Interim Statements of Cash Flows (all amounts in USD, in thousands) | ||||||||
| Nine months ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| Cash flows from operating activities | ||||||||
| Net Loss | (8,344 | ) | (5,213 | ) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation of property and equipment | 74 | 73 | ||||||
| Amortization of intangible asset | 103 | 66 | ||||||
| Amortization of customer incentive asset | 22 | - | ||||||
| Provision for credit losses | - | 46 | ||||||
| Stock-based compensation | 1,309 | 176 | ||||||
| Amortization of right-of-use assets | 215 | 65 | ||||||
| Amortization of convertible note discount | 294 | - | ||||||
| Changes in fair value of convertible notes at fair value and warrant liability | (91 | ) | 1,405 | |||||
| Change in fair value of forward purchase derivative liability | 604 | - | ||||||
| Accretion of cumulative mandatorily redeemable common and preferred stock liability | 83 | 71 | ||||||
| Loss on extinguishment of debt | - | 391 | ||||||
| Gain on extinguishment of payable | (612 | ) | - | |||||
| Unrealized foreign exchange gain/(loss) | - | (7 | ) | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable, current, net | (208 | ) | 87 | |||||
| Unbilled revenue | (20 | ) | 56 | |||||
| Prepaid expenses and other current assets | 185 | (44 | ) | |||||
| Accounts receivable, net | - | 4 | ||||||
| Other assets | 4 | (7 | ) | |||||
| Accounts payable | (156 | ) | 1,989 | |||||
| Operating lease liabilities | (232 | ) | (53 | ) | ||||
| Accrued expenses and other current liabilities | 1,963 | 461 | ||||||
| Deferred revenue | - | (54 | ) | |||||
| Net cash used in operating activities | (4,807 | ) | (488 | ) | ||||
| Cash flows from investing activities | ||||||||
| Costs capitalized for internally developed software | (157 | ) | (72 | ) | ||||
| Purchases of property and equipment | (27 | ) | (8 | ) | ||||
| Net cash used in investing activities | (184 | ) | (80 | ) | ||||
| Cash flows from financing activities | ||||||||
| Proceeds from Convertible notes payable, current | 2,050 | 180 | ||||||
| Repayment of Convertible notes payable, current | (224 | ) | - | |||||
| Proceeds received from sales of forward purchase agreement shares | 679 | - | ||||||
| Payment of director and officer insurance liability (short term debt) | (376 | ) | - | |||||
| Proceeds from director and officer insurance liability (short term debt) | 98 | - | ||||||
| Payment of deferred transaction costs | - | (5 | ) | |||||
| Net cash (used in) / provided by financing activities | 2,227 | 175 | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (4 | ) | (1 | ) | ||||
| Net change in cash and cash equivalents | (2,767 | ) | (394 | ) | ||||
| Cash and cash equivalents at beginning of the period | 4,221 | 500 | ||||||
| Cash and cash equivalents at end of the period | 1,454 | 106 | ||||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash paid for income taxes | 22 | 18 | ||||||
| Cash paid for interest | 12 | - | ||||||
| Non-cash investing and financing activities: | ||||||||
| Deemed dividend related to shortfall warrant modification | 84 | - | ||||||
| Common Stock issued upon cashless exercise of stock options | 39 | 707 | ||||||
| Unpaid deferred transaction costs as of the end of the period | - | 507 | ||||||
| Waiver of deferred transaction costs as of the end of the period | - | 505 | ||||||
| Issuance of shares vested upon repayment and forgiveness of 2023 Promissory Notes | - | 3 | ||||||
| Warrants issues in connection with new Convertible Notes (Refer note 6) | 231 | - | ||||||
| Shortfall warrant amendment (Refer note 16) | 494 | - | ||||||
| Issuance of common stock as consideration payable to customer (Refer note 4) | 578 | |||||||
| Issuance of common stock to settle outstanding severance pay of employees (Refer note 9) | 460 | - | ||||||
| Issuance of common stock to settle outstanding invoices of vendor (Refer note 18) | 1,298 | - | ||||||
| Adjustment of share subscription receivable on account of partial early termination of forward contract (Refer note 15) | 9,588 | |||||||
| (Loss)/Gain on extinguishment of debt | - | (391 | ) |
The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment